Pipeline

At BioStem Technologies, we invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients and physicians. The development of our novel therapeutics is classified into three stages: Pre-clinical, Phase I, and Phase II. These studies into the safety and efficacy of investigational products provide data to support applications to regulators for approval. The content of our development pipeline will change over time as new projects progress from research to development and from development to the market.